Gilead widens licensing pacts with Indian drug manufacturers
Gilead has also entered into a licensing agreement with the Medicines Patent Pool Foundation. The agreement allows the Indian firms to market the generic Elvitegravir, Cobicistat and Quad.

Gilead has also entered into a licensing agreement with the Medicines Patent Pool Foundation. The agreement allows the Indian firms to market the generic Elvitegravir, Cobicistat and Quad.

Fondaparinux Sodium Injection is the generic version of GlaxoSmithKline’s (GSK) Arixtra which is indicated as a treatment for acute deep vein thrombosis when administered in conjunction with warfarin

Ursodiol is a generic version of Axcan’s Urso 250mg and Urso Forte tablets. The final approval has been given for Glenmark’s abbreviated new drug application (ANDA) for generic

Under the agreement, MANF-based therapeutic will be developed using Generex’s RapidMist technology in conjunction with oral-insulin spray technology Oral-lyn. Amarantus chief scientific officer John Commissiong said MANF’s profile

Perifosine, which is an oral anticancer drug that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, has been granted orphan drug status by the US Food and

As per the terms of the deal, Orion will license the Chinese marketing rights of these two drugs to Eisai. Eisai will distribute the drugs through its Chinese

Under the renewal agreement, Ipsen will provide funding for research programs carried out at the Salk Institute by researchers on therapeutic concepts for the treatment of pituitary adenomas,

ARRY-543 is currently entering Phase 2 development for solid tumors. As per the terms of the agreement, ASLAN Pharma will provide funding and will also be responsible for

Connecticut-based Arch Chemicals and its subsidiaries provide chemistry-based and related solutions in the areas of water treatment, personal care, health and hygiene, industrial preservation and protection, and wood

As per the agreement, DATATRAK will offer trial design and clinical data management services to its client. The eClinical solutions provider said that the new contract strengthens its